Speaker Profile
Ph.D., Vice President, Translational PKPD, Genentech
Biography
Amrita V. Kamath, PhD, MBA, is Vice President and Head of the Translational PKPD department at Genentech. Her department is accountable for providing nonclinical, translational and investigative PKPD guidance for Genentechs large molecule therapeutics (including antibodies, bispecifics, antibody-drug conjugates, peptides, vaccines, cell and gene therapies) from early-stage research through approval. Prior to joining Genentech in 2006, she was at Bristol-Myers Squibb in the Metabolism and Pharmacokinetics department working on small molecule therapeutics. She received her B.Pharm from the University of Bombay, followed by a PhD in Pharmaceutics from the State University of New York at Buffalo, and a MBA from Rutgers University. During her 25 years in the industry, she has played a key role in advancing several molecules from discovery into clinical development in several therapeutic areas by applying PKPD principles in guiding molecule selection, characterization, and prediction of human PK and clinical efficacious doses.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Maryland Franklin, Labcorp
- Cross-Application of Oncology Drugs in Rare Diseases
- Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2025 Award Ceremony
Luminary Honoree: David R. Liu, Broad Institute & Crystal Mackal, Stanford University
Pioneer Honoree: Drew Weissman, Penn Medicine
- Breakthroughs in Cancer Immunotherapy: mRNA Vaccines and CAR T-Cell Advances (PANEL)
Chair: Ira Mellman, Medici Therapeutics
- Drew Weissman, Penn Medicine
- Crystal Mackal, Stanford University - Next-Generation ADCs: Challenges and Innovations in Immunotherapy Combinations (PANEL)
Chair: Sandhya Girish, Gilead
- Bin Liu, UCSF
- Hanspeter Gerber, Sutro Bioscience
- Amrita Kamath, Genentech
- Stephen Eck, MacroGenics - Strategic IP Management in Cell and Gene Therapy: Navigating Legal and Practical Challenges
- Janet Xiao, Morrison & Foerster LLP
- Keynote: Base Editing, Prime Editing, and Targeted Gene Integration: Precision Therapeutic Genome Editingn
- David R. Liu, Broad Institute
- Advances in Allogeneic Cell Therapies: Overcoming Hurdles and Expanding Applications (PANEL)
Chair: Elliot Norry, Adaptimmune
- Larry Lamb, IN8bio
- Indu Ramachandran, Century Therapeutics - Bottlenecks in Manufacturing of Cell Therapies
- Fabian Gerlinghaus, Cellares
- Transforming Cancer Treatment: Stem Cell and Gene Therapy Breakthroughs
Chair: Catriona Jamieson, UCSD Health
- Irv Weisman, Stanford
- Collaborations Advancing Genetics-based Diagnostic Testing for Cell and Gene Therapy
Chair: Maryland Franklin, Labcorp
- Data-Driven Innovations in Oncology Cell Therapy Trials
- Prabhu Snehit, Stanford
- Advancements and Future Directions in Therapeutic Ultrasound for Precision Medicine
Chair: Masha Stromme, EXACT Therapeutics
- John de Groot, UCSF
- Bhaskar Ramamurthy, Cordance Medical
- Raag Airan, Stanford
